SFDA grants conditional approval for Anktiva with immunotherapy in metastatic NSCLC after prior therapy, and with BCG for high-risk NMI...

KFSHRC Jeddah launches a post-transplant booster dose for bone marrow transplant patients, enhancing engraftment and reducing relapse w...

The Vilcek Foundation announces Dr. Jedd Wolchok's board appointment, highlighting his contributions to immunotherapy and cancer resear...

BioMed X partners with Merck to start a new immuno-oncology project in Heidelberg, aiming to develop therapies for solid tumors....